Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.53
+0.6%
$113.64
$89.67
$121.64
$186.58B0.745.22 million shs3.58 million shs
Aetna Inc. stock logo
AET
Aetna
$212.70
$212.70
$166.88
$213.36
$69.64B0.713.69 million shs11.86 million shs
Carnival Co. & plc stock logo
CCL
Carnival Co. &
$15.08
-0.7%
$15.58
$8.72
$19.74
$16.92B2.5427.17 million shs20.46 million shs
The Cigna Group stock logo
CI
The Cigna Group
$354.47
0.0%
$349.88
$240.50
$365.71
$103.63B0.561.26 million shs830,527 shs
Humana Inc. stock logo
HUM
Humana
$305.90
-1.8%
$327.77
$299.23
$541.21
$36.86B0.451.91 million shs1.21 million shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.02%+0.23%-5.38%-4.00%-1.12%
Aetna Inc. stock logo
AET
Aetna
0.00%0.00%0.00%0.00%0.00%
Carnival Co. & plc stock logo
CCL
Carnival Co. &
-0.03%+6.80%-7.71%-4.74%+72.15%
The Cigna Group stock logo
CI
The Cigna Group
+0.02%+0.59%-2.40%+19.02%+42.83%
Humana Inc. stock logo
HUM
Humana
0.00%-6.83%-11.77%-15.32%-39.48%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9936 of 5 stars
3.35.04.24.53.12.52.5
Aetna Inc. stock logo
AET
Aetna
N/AN/AN/AN/AN/AN/AN/AN/A
Carnival Co. & plc stock logo
CCL
Carnival Co. &
4.9086 of 5 stars
4.43.00.03.12.63.32.5
The Cigna Group stock logo
CI
The Cigna Group
4.8486 of 5 stars
2.55.02.54.22.62.52.5
Humana Inc. stock logo
HUM
Humana
4.9984 of 5 stars
4.23.03.33.93.03.33.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.67
Moderate Buy$121.5012.99% Upside
Aetna Inc. stock logo
AET
Aetna
N/AN/AN/AN/A
Carnival Co. & plc stock logo
CCL
Carnival Co. &
2.80
Moderate Buy$21.4742.40% Upside
The Cigna Group stock logo
CI
The Cigna Group
2.92
Moderate Buy$362.142.16% Upside
Humana Inc. stock logo
HUM
Humana
2.47
Hold$424.5038.77% Upside

Current Analyst Ratings

Latest ABT, AET, CI, HUM, and CCL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Humana Inc. stock logo
HUM
Humana
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$415.00 ➝ $353.00
4/25/2024
Humana Inc. stock logo
HUM
Humana
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$391.00 ➝ $360.00
4/25/2024
Humana Inc. stock logo
HUM
Humana
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$334.00 ➝ $326.00
4/25/2024
Humana Inc. stock logo
HUM
Humana
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$415.00 ➝ $370.00
4/24/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$124.00
4/22/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$141.00 ➝ $140.00
4/22/2024
Carnival Co. & plc stock logo
CCL
Carnival Co. &
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/22/2024
Humana Inc. stock logo
HUM
Humana
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$411.00 ➝ $381.00
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/10/2024
The Cigna Group stock logo
CI
The Cigna Group
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$384.00
4/10/2024
Humana Inc. stock logo
HUM
Humana
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$391.00
(Data available from 4/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.65$6.36 per share16.90$22.36 per share4.81
Aetna Inc. stock logo
AET
Aetna
$60.54B1.15$12.44 per share17.10$56.70 per share3.75
Carnival Co. & plc stock logo
CCL
Carnival Co. &
$21.59B0.78$2.26 per share6.67$5.95 per share2.53
The Cigna Group stock logo
CI
The Cigna Group
$195.27B0.53$35.84 per share9.89$158.03 per share2.24
Humana Inc. stock logo
HUM
Humana
$106.37B0.35$34.26 per share8.93$134.32 per share2.28

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2133.5021.002.5913.96%20.32%10.59%7/18/2024 (Estimated)
Aetna Inc. stock logo
AET
Aetna
$1.90B$9.8621.5717.151.825.99%20.78%6.22%N/A
Carnival Co. & plc stock logo
CCL
Carnival Co. &
-$75M$0.2658.0010.47N/A1.79%7.75%1.02%6/24/2024 (Estimated)
The Cigna Group stock logo
CI
The Cigna Group
$5.16B$17.3920.3811.101.092.64%13.59%4.12%5/2/2024 (Confirmed)
Humana Inc. stock logo
HUM
Humana
$2.49B$16.0619.0514.331.791.82%17.76%5.63%8/7/2024 (Estimated)

Latest ABT, AET, CI, HUM, and CCL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
The Cigna Group stock logo
CI
The Cigna Group
$6.16N/A-$6.16N/AN/AN/A  
4/24/2024Q1 24
Humana Inc. stock logo
HUM
Humana
$6.12$7.23+$1.11$8.35$28.52 billion$29.61 billion      
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
3/27/2024Q1 24
Carnival Co. & plc stock logo
CCL
Carnival Co. &
-$0.18-$0.14+$0.04-$0.11$5.42 billion$5.41 billion      
2/2/202412/31/2023
The Cigna Group stock logo
CI
The Cigna Group
$6.54$6.79+$0.25$10.09$48.91 billion$51.15 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.05%+12.31%68.54%53 Years
Aetna Inc. stock logo
AET
Aetna
$2.000.94%N/A20.28%N/A
Carnival Co. & plc stock logo
CCL
Carnival Co. &
N/AN/AN/AN/AN/A
The Cigna Group stock logo
CI
The Cigna Group
$5.601.58%+397.32%32.20%4 Years
Humana Inc. stock logo
HUM
Humana
$3.541.16%+12.29%22.04%7 Years

Latest ABT, AET, CI, HUM, and CCL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/18/2024
Humana Inc. stock logo
HUM
Humana
quarterly$0.88501.09%6/28/20246/28/20247/26/2024
4/24/2024
The Cigna Group stock logo
CI
The Cigna Group
quarterly$1.401.59%6/4/20246/4/20246/20/2024
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
2/15/2024
Humana Inc. stock logo
HUM
Humana
quarterly$0.88500.97%3/27/20243/29/20244/26/2024
2/2/2024
The Cigna Group stock logo
CI
The Cigna Group
quarterly$1.401.82%3/5/20243/6/20243/21/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
Aetna Inc. stock logo
AET
Aetna
0.42
0.79
0.79
Carnival Co. & plc stock logo
CCL
Carnival Co. &
4.27
0.36
0.32
The Cigna Group stock logo
CI
The Cigna Group
0.61
0.67
0.67
Humana Inc. stock logo
HUM
Humana
0.77
1.67
1.59

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Aetna Inc. stock logo
AET
Aetna
82.34%
Carnival Co. & plc stock logo
CCL
Carnival Co. &
67.19%
The Cigna Group stock logo
CI
The Cigna Group
86.99%
Humana Inc. stock logo
HUM
Humana
92.38%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
1.10%
Aetna Inc. stock logo
AET
Aetna
1.21%
Carnival Co. & plc stock logo
CCL
Carnival Co. &
11.00%
The Cigna Group stock logo
CI
The Cigna Group
0.60%
Humana Inc. stock logo
HUM
Humana
0.32%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.72 billionOptionable
Aetna Inc. stock logo
AET
Aetna
N/A327.40 millionN/AOptionable
Carnival Co. & plc stock logo
CCL
Carnival Co. &
92,0001.12 billion998.87 millionOptionable
The Cigna Group stock logo
CI
The Cigna Group
72,500292.36 million290.60 millionOptionable
Humana Inc. stock logo
HUM
Humana
67,600120.50 million120.12 millionOptionable

ABT, AET, CI, HUM, and CCL Headlines

SourceHeadline
Intact Investment Management Inc. Grows Stake in Humana Inc. (NYSE:HUM)Intact Investment Management Inc. Grows Stake in Humana Inc. (NYSE:HUM)
marketbeat.com - April 28 at 12:55 PM
Russell Investments Group Ltd. Acquires 125,697 Shares of Humana Inc. (NYSE:HUM)Russell Investments Group Ltd. Acquires 125,697 Shares of Humana Inc. (NYSE:HUM)
marketbeat.com - April 27 at 2:20 PM
Humana (NYSE:HUM) Price Target Lowered to $370.00 at OppenheimerHumana (NYSE:HUM) Price Target Lowered to $370.00 at Oppenheimer
americanbankingnews.com - April 27 at 6:32 AM
FY2024 EPS Estimates for Humana Inc. (NYSE:HUM) Lowered by AnalystFY2024 EPS Estimates for Humana Inc. (NYSE:HUM) Lowered by Analyst
americanbankingnews.com - April 27 at 4:04 AM
Humana (NYSE:HUM) Trading Down 1.1% Following Analyst DowngradeHumana (NYSE:HUM) Trading Down 1.1% Following Analyst Downgrade
americanbankingnews.com - April 27 at 3:16 AM
Leerink Partnrs Comments on Humana Inc.s Q2 2024 Earnings (NYSE:HUM)Leerink Partnrs Comments on Humana Inc.'s Q2 2024 Earnings (NYSE:HUM)
americanbankingnews.com - April 27 at 2:20 AM
Buy Rating Affirmed for Humana Despite Earnings Forecast Adjustment: Growth and Fundamentals Remain StrongBuy Rating Affirmed for Humana Despite Earnings Forecast Adjustment: Growth and Fundamentals Remain Strong
markets.businessinsider.com - April 27 at 1:55 AM
Stevens Capital Management LP Sells 4,132 Shares of Humana Inc. (NYSE:HUM)Stevens Capital Management LP Sells 4,132 Shares of Humana Inc. (NYSE:HUM)
marketbeat.com - April 26 at 5:58 PM
Humanas Solid Q1 Earnings Beat Tempered by Reduced GuidanceHumana's Solid Q1 Earnings Beat Tempered by Reduced Guidance
fool.com - April 26 at 2:44 PM
Humanas 2025 earnings, pricing decisions and membership may take hit from MA rate noticeHumana's 2025 earnings, pricing decisions and membership may take hit from MA rate notice
healthcarefinancenews.com - April 26 at 2:44 PM
Humana (NYSE:HUM)  Shares Down 1.1%  After Analyst DowngradeHumana (NYSE:HUM) Shares Down 1.1% After Analyst Downgrade
marketbeat.com - April 26 at 12:34 PM
Humana Inc. (NYSE:HUM) to Post FY2024 Earnings of $16.04 Per Share, Cantor Fitzgerald ForecastsHumana Inc. (NYSE:HUM) to Post FY2024 Earnings of $16.04 Per Share, Cantor Fitzgerald Forecasts
marketbeat.com - April 26 at 9:46 AM
Humana warns of tough times ahead for Medicare AdvantageHumana warns of tough times ahead for Medicare Advantage
wdrb.com - April 26 at 9:43 AM
Humana’s Strong Q1 Performance and Cost Efficiency Bolster Buy Rating Despite 2025 UncertaintiesHumana’s Strong Q1 Performance and Cost Efficiency Bolster Buy Rating Despite 2025 Uncertainties
markets.businessinsider.com - April 26 at 9:43 AM
Humana (NYSE:HUM) Trading Down 2.1% Following Analyst DowngradeHumana (NYSE:HUM) Trading Down 2.1% Following Analyst Downgrade
americanbankingnews.com - April 26 at 1:36 AM
Analysts revisit Humana stock price targets amid Medicare Advantage hitAnalysts revisit Humana stock price targets amid Medicare Advantage hit
thestreet.com - April 25 at 11:42 PM
Humana Expands Prior Auth. Partnership With Cohere HealthHumana Expands Prior Auth. Partnership With Cohere Health
healthleadersmedia.com - April 25 at 6:41 PM
Humana’s Strong Performance and Positive Outlook Affirm Buy RatingHumana’s Strong Performance and Positive Outlook Affirm Buy Rating
markets.businessinsider.com - April 25 at 6:41 PM
Humana Stock Is Down Despite Earnings BeatHumana Stock Is Down Despite Earnings Beat
msn.com - April 25 at 6:41 PM
Humana (NYSE:HUM) Given New $353.00 Price Target at Royal Bank of CanadaHumana (NYSE:HUM) Given New $353.00 Price Target at Royal Bank of Canada
marketbeat.com - April 25 at 2:02 PM
Humana Inc. (NYSE:HUM) Q1 2024 Earnings Call TranscriptHumana Inc. (NYSE:HUM) Q1 2024 Earnings Call Transcript
finance.yahoo.com - April 25 at 1:41 PM
Humana (NYSE:HUM) Trading Down 2.1% After Analyst DowngradeHumana (NYSE:HUM) Trading Down 2.1% After Analyst Downgrade
marketbeat.com - April 25 at 12:07 PM
Humana Healthy Horizons Commits $500K to Improve Health of LouisianiansHumana Healthy Horizons Commits $500K to Improve Health of Louisianians
businesswire.com - April 25 at 11:20 AM
Alaska Permanent Fund Corp Makes New $4.57 Million Investment in Humana Inc. (NYSE:HUM)Alaska Permanent Fund Corp Makes New $4.57 Million Investment in Humana Inc. (NYSE:HUM)
marketbeat.com - April 25 at 10:32 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Aetna logo

Aetna

NYSE:AET
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Carnival Co. & logo

Carnival Co. &

NYSE:CCL
Carnival Corporation & plc engages in the provision of leisure travel services in North America, Australia, Europe, Asia, and internationally. The company operates through four segments: NAA Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Other. It operates port destinations, private islands, and a solar park, as well as owns and operates hotels, lodges, glass-domed railcars, and motor coaches. The company offers its services under the Carnival Cruise Line, Princess Cruises, Holland America Line, Seabourn, Costa Cruises, AIDA Cruises, P&O Cruises, and Cunard brand. Additionally, it sells its cruises primarily through travel agents, tour operators, vacation planners, and websites. Carnival Corporation & plc was founded in 1972 and is headquartered in Miami, Florida.
The Cigna Group logo

The Cigna Group

NYSE:CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Humana logo

Humana

NYSE:HUM
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.